RCM Tech | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 70.29 M

Revenue: As of FY2025 Q3, the actual value is USD 70.29 M, beating the estimate of USD 67.34 M.

EPS: As of FY2025 Q3, the actual value is USD 0.3, missing the estimate of USD 0.34.

EBIT: As of FY2025 Q3, the actual value is USD 4.522 M.

Revenue: $30.0 million for the thirteen weeks ended September 27, 2025, increased by 13.0% from $26.6 million in the comparable prior-year period.
Gross Profit: $9.0 million for the thirteen weeks ended September 27, 2025, increased by 8.5% from $8.3 million in the comparable prior-year period.
Gross Profit Margin: 30.0% for the thirteen weeks ended September 27, 2025, decreased from 31.2% in the comparable prior-year period.
Operating Income: $2.7 million for the thirteen weeks ended September 27, 2025, decreased from $3.2 million in the comparable prior-year period.
SGA Expense: $6.2 million for the thirteen weeks ended September 27, 2025, increased from $4.9 million in the comparable prior-year period.

Revenue: $31.4 million for the thirteen weeks ended September 27, 2025, increased by 30.0% from $24.2 million in the comparable prior-year period.
Gross Profit: $6.9 million for the thirteen weeks ended September 27, 2025, increased by 17.3% from $5.9 million in the comparable prior-year period.
Gross Profit Margin: 22.0% for the thirteen weeks ended September 27, 2025, decreased from 24.4% in the comparable prior-year period.
Operating Income: $3.8 million for the thirteen weeks ended September 27, 2025, increased from $2.9 million in the comparable prior-year period.
SGA Expense: Approximately $2.9 million for both periods presented.

Revenue: $8.9 million for the thirteen weeks ended September 27, 2025, decreased by 8.0% from $9.6 million in the comparable prior-year period.
Gross Profit: $3.5 million for the thirteen weeks ended September 27, 2025, decreased by 4.2% from $3.7 million in the comparable prior-year period.
Gross Profit Margin: 39.6% for the thirteen weeks ended September 27, 2025, increased from 38.0% in the comparable prior-year period.
Operating Income: $2.0 million for the thirteen weeks ended September 27, 2025, increased from $1.9 million in the comparable prior-year period.
SGA Expense: $1.4 million for the thirteen weeks ended September 27, 2025, decreased from $1.6 million in the comparable prior-year period.

SGA Expense: $4.4 million for the thirteen weeks ended September 27, 2025, increased from $3.6 million in the comparable prior-year period.

Core Business Focus: The Company emphasizes the need for businesses to adopt advanced life sciences, IT, and engineering solutions, including AI, QbD, and process automation, to enhance systems and processes. AI is expected to improve data-driven decision-making and predictive analytics, while QbD ensures quality at every development stage, and process automation aims to streamline workflows and increase efficiency.
Non-Core Business: The Company aims to optimize its business model as a single-source provider of business and technology solutions, offering an integrated suite of services through a global delivery platform.